Trial
NCT01488708
On Open-Label Study in Participants With Systemic Lupus Erythematosus
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Systemic Lupus Erythematosus
Intervention
LY2127399
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-05-17